These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3259035)

  • 21. [Reaction between myasthenia patients' sera and the antigenic structure of the surface of thymic lymphocytes of healthy subjects and myasthenia gravis patients].
    Gnezditskaia EV; Beletskaia LV; Ippolitov IKh; Malkina LA; Shagal DI
    Biull Eksp Biol Med; 1980 Oct; 90(10):462-4. PubMed ID: 7000198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
    Zhang J; Zhou WB; Wang HL; Guo SS
    Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current status of the physiopathology and treatment of myasthenia gravis].
    Vázquez A; Fernández O
    Rev Clin Esp; 1978 May; 149(4):321-6. PubMed ID: 694105
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of thymus gland function for the prognosis of the course of myasthenia gravis].
    Lobzin VS; Poliakova LA; Fedotova TA; Verbitskaia IuB
    Klin Med (Mosk); 1988 Dec; 66(12):78-80. PubMed ID: 3230857
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pathogenesis of partial neuromuscular block in experimental myasthenia gravis].
    Kalden JR
    Verh Dtsch Ges Inn Med; 1973; 79():588-9. PubMed ID: 4790302
    [No Abstract]   [Full Text] [Related]  

  • 26. Altered intrathymic T-cell repertoire in human myasthenia gravis.
    Truffault F; Cohen-Kaminsky S; Khalil I; Levasseur P; Berrih-Aknin S
    Ann Neurol; 1997 Jun; 41(6):731-41. PubMed ID: 9189034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A patient with a relapse of myasthenia gravis after a 13-year remission following successful treatment by mediastinal irradiation and corticosteroid therapy].
    Yahikozawa H; Koh CS; Inoue A; Hashimoto T; Yanagisawa N
    No To Shinkei; 1995 Jun; 47(6):585-8. PubMed ID: 7605688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myogenesis in thymic transplants in the severe combined immunodeficient mouse model of myasthenia gravis. Differentiation of thymic myoid cells into striated muscle cells.
    Spuler S; Marx A; Kirchner T; Hohlfeld R; Wekerle H
    Am J Pathol; 1994 Oct; 145(4):766-70. PubMed ID: 7943168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-2 and coculture with thymic epithelial cells synergistically induce prothymocyte differentiation and proliferation.
    Wiranowska M; Kaido T; Caspritz G; Cook J; Hadden J
    Thymus; 1987; 10(3-4):231-45. PubMed ID: 3501186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The myasthic srome].
    Baumann I; Raue I
    Z Gesamte Inn Med; 1966 Aug; 21(16):481-4. PubMed ID: 5991141
    [No Abstract]   [Full Text] [Related]  

  • 31. Bilineage hematopoietic inhibitor and T lymphocyte dysfunction in a patient with pure red cell aplasia, myasthenia gravis and thymoma.
    Murase T
    Exp Hematol; 1993 Mar; 21(3):451-5. PubMed ID: 8440342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.
    Willcox HN; Newsom-Davis J; Calder LR
    Clin Exp Immunol; 1984 Oct; 58(1):97-106. PubMed ID: 6236921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The importance of thymus gland in severe non-dynamic thyrotoxicoses].
    Bansi HW
    Med Klin; 1968 Aug; 63(32):1245-52. PubMed ID: 5722900
    [No Abstract]   [Full Text] [Related]  

  • 34. Myasthenia gravis, chronic lymphocytic leukemia, and autoimmune hemolytic anemia. "A spectrum of thymic abnormalities?
    Cohen SM; Waxman S
    Arch Intern Med; 1967 Dec; 120(6):717-20. PubMed ID: 4862343
    [No Abstract]   [Full Text] [Related]  

  • 35. Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia.
    Cohen-Kaminsky S; Devergne O; Delattre RM; Klingel-Schmitt I; Emilie D; Galanaud P; Berrih-Aknin S
    Eur Cytokine Netw; 1993; 4(2):121-32. PubMed ID: 8318672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymopoietin and myasthenia gravis: neostigmine-responsive neuromuscular block produced in mice by a synthetic peptide fragment of thymopoietin.
    Goldstein G; Schlesinger DH
    Lancet; 1975 Aug; 2(7928):256-9. PubMed ID: 49801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myasthenia gravis.
    Quick DT
    Int Anesthesiol Clin; 1968; 6(1):261-8. PubMed ID: 5704462
    [No Abstract]   [Full Text] [Related]  

  • 38. The thymus and myasthenia gravis.
    Ragheb S; Lisak RP
    Chest Surg Clin N Am; 2001 May; 11(2):311-27, x. PubMed ID: 11413758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Myasthenia gravis and hormones].
    Uono M
    Horumon To Rinsho; 1968 Mar; 16(3):189-95. PubMed ID: 4877893
    [No Abstract]   [Full Text] [Related]  

  • 40. Lymphocyte subpopulations in non-neoplastic thymus from myasthenia gravis patients.
    Piantelli M; Musiani P; Lauriola L; Carbone A; Tonali P; Dina MA
    Clin Exp Immunol; 1980 Jul; 41(1):19-24. PubMed ID: 6969152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.